Corrigendum re “A Preoperative Nomogram to Predict Renal Function Insufficiency for Cisplatin-based Adjuvant Chemotherapy Following Minimally Invasive Radical Nephroureterectomy (ROBUUST Collaborative Group)” [Eur Urol Focus 2022;8:173–81] (European Urology Focus (2022) 8(1) (173–181), (S2405456921000158), (10.1016/j.euf.2021.01.014))

Zhenjie Wu; Qi Chen; Hooman Djaladat; Andrea Minervini; Robert G. Uzzo; Chandru Sundaram; Koon H. Rha; Mark L. Gonzalgo; Reza Mehrazin; Elio Mazzone; Jamil Marcus; Alyssa Danno; James Porter; Aeen Asghar; Fady Ghali; Georgi Guruli; Antoin Douglawi; Giovanni Cacciamani; Alireza Ghoreifi; Giuseppe Simone; Vitaly Margulis; Matteo Ferro; Riccardo Tellini; Andrea Mari; Abhishek Srivastava; James Steward; Ali Al-Qathani; Ahmad Al-Mujalhem; Amit Satish Bhattu; Alexander Mottrie; Firas Abdollah; Daniel D. Eun; Ithaar Derweesh; Alessandro Veccia; Riccardo Autorino; Linhui Wang

doi:10.1016/j.euf.2022.12.010

Corrigendum re “A Preoperative Nomogram to Predict Renal Function Insufficiency for Cisplatin-based Adjuvant Chemotherapy Following Minimally Invasive Radical Nephroureterectomy (ROBUUST Collaborative Group)” [Eur Urol Focus 2022;8:173–81] (European Urology Focus (2022) 8(1) (173–181), (S2405456921000158), (10.1016/j.euf.2021.01.014))

Zhenjie Wu, Qi Chen, Hooman Djaladat, Andrea Minervini, Robert G. Uzzo, Chandru Sundaram, Koon H. Rha, Mark L. Gonzalgo, Reza Mehrazin, Elio Mazzone, Jamil Marcus, Alyssa Danno, James Porter, Aeen Asghar, Fady Ghali, Georgi Guruli, Antoin Douglawi, Giovanni Cacciamani, Alireza Ghoreifi, Giuseppe SimoneVitaly Margulis, Matteo Ferro, Riccardo Tellini, Andrea Mari, Abhishek Srivastava, James Steward, Ali Al-Qathani, Ahmad Al-Mujalhem, Amit Satish Bhattu, Alexander Mottrie, Firas Abdollah, Daniel D. Eun, Ithaar Derweesh, Alessandro Veccia, Riccardo Autorino, Linhui Wang

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

In the original publication, affiliation p was listed as Department of Urology, Regina Elena National Cancer Institute, Rome, Italy. The authors would like it to be noted that the institution for this affiliation has IRCCS accreditation and the correct institution name is correctly listed above. Conflicts of interest: The authors have nothing to disclose.

Original language	English (US)
Pages (from-to)	502
Number of pages	1
Journal	European Urology Focus
Volume	10
Issue number	3
DOIs	https://doi.org/10.1016/j.euf.2022.12.010
State	Published - May 2024

ASJC Scopus subject areas

Urology

Access to Document

10.1016/j.euf.2022.12.010

Fingerprint

Dive into the research topics of 'Corrigendum re “A Preoperative Nomogram to Predict Renal Function Insufficiency for Cisplatin-based Adjuvant Chemotherapy Following Minimally Invasive Radical Nephroureterectomy (ROBUUST Collaborative Group)” [Eur Urol Focus 2022;8:173–81] (European Urology Focus (2022) 8(1) (173–181), (S2405456921000158), (10.1016/j.euf.2021.01.014))'. Together they form a unique fingerprint.

Cite this

Wu, Z., Chen, Q., Djaladat, H., Minervini, A., Uzzo, R. G., Sundaram, C., Rha, K. H., Gonzalgo, M. L., Mehrazin, R., Mazzone, E., Marcus, J., Danno, A., Porter, J., Asghar, A., Ghali, F., Guruli, G., Douglawi, A., Cacciamani, G., Ghoreifi, A., ... Wang, L. (2024). Corrigendum re “A Preoperative Nomogram to Predict Renal Function Insufficiency for Cisplatin-based Adjuvant Chemotherapy Following Minimally Invasive Radical Nephroureterectomy (ROBUUST Collaborative Group)” [Eur Urol Focus 2022;8:173–81] (European Urology Focus (2022) 8(1) (173–181), (S2405456921000158), (10.1016/j.euf.2021.01.014)). European Urology Focus, 10(3), 502. https://doi.org/10.1016/j.euf.2022.12.010

Corrigendum re “A Preoperative Nomogram to Predict Renal Function Insufficiency for Cisplatin-based Adjuvant Chemotherapy Following Minimally Invasive Radical Nephroureterectomy (ROBUUST Collaborative Group)” [Eur Urol Focus 2022;8:173–81] (European Urology Focus (2022) 8(1) (173–181), (S2405456921000158), (10.1016/j.euf.2021.01.014)). / Wu, Zhenjie; Chen, Qi; Djaladat, Hooman et al.
In: European Urology Focus, Vol. 10, No. 3, 05.2024, p. 502.

Research output: Contribution to journal › Comment/debate › peer-review

Wu, Z, Chen, Q, Djaladat, H, Minervini, A, Uzzo, RG, Sundaram, C, Rha, KH, Gonzalgo, ML, Mehrazin, R, Mazzone, E, Marcus, J, Danno, A, Porter, J, Asghar, A, Ghali, F, Guruli, G, Douglawi, A, Cacciamani, G, Ghoreifi, A, Simone, G, Margulis, V, Ferro, M, Tellini, R, Mari, A, Srivastava, A, Steward, J, Al-Qathani, A, Al-Mujalhem, A, Satish Bhattu, A, Mottrie, A, Abdollah, F, Eun, DD, Derweesh, I, Veccia, A, Autorino, R & Wang, L 2024, 'Corrigendum re “A Preoperative Nomogram to Predict Renal Function Insufficiency for Cisplatin-based Adjuvant Chemotherapy Following Minimally Invasive Radical Nephroureterectomy (ROBUUST Collaborative Group)” [Eur Urol Focus 2022;8:173–81] (European Urology Focus (2022) 8(1) (173–181), (S2405456921000158), (10.1016/j.euf.2021.01.014))', European Urology Focus, vol. 10, no. 3, pp. 502. https://doi.org/10.1016/j.euf.2022.12.010

Wu Z, Chen Q, Djaladat H, Minervini A, Uzzo RG, Sundaram C et al. Corrigendum re “A Preoperative Nomogram to Predict Renal Function Insufficiency for Cisplatin-based Adjuvant Chemotherapy Following Minimally Invasive Radical Nephroureterectomy (ROBUUST Collaborative Group)” [Eur Urol Focus 2022;8:173–81] (European Urology Focus (2022) 8(1) (173–181), (S2405456921000158), (10.1016/j.euf.2021.01.014)). European Urology Focus. 2024 May;10(3):502. doi: 10.1016/j.euf.2022.12.010

Wu, Zhenjie ; Chen, Qi ; Djaladat, Hooman et al. / Corrigendum re “A Preoperative Nomogram to Predict Renal Function Insufficiency for Cisplatin-based Adjuvant Chemotherapy Following Minimally Invasive Radical Nephroureterectomy (ROBUUST Collaborative Group)” [Eur Urol Focus 2022;8:173–81] (European Urology Focus (2022) 8(1) (173–181), (S2405456921000158), (10.1016/j.euf.2021.01.014)). In: European Urology Focus. 2024 ; Vol. 10, No. 3. pp. 502.

@article{0156dea6a5c048ec966ba544124d3513,

title = "Corrigendum re “A Preoperative Nomogram to Predict Renal Function Insufficiency for Cisplatin-based Adjuvant Chemotherapy Following Minimally Invasive Radical Nephroureterectomy (ROBUUST Collaborative Group)” [Eur Urol Focus 2022;8:173–81] (European Urology Focus (2022) 8(1) (173–181), (S2405456921000158), (10.1016/j.euf.2021.01.014))",

abstract = "In the original publication, affiliation p was listed as Department of Urology, Regina Elena National Cancer Institute, Rome, Italy. The authors would like it to be noted that the institution for this affiliation has IRCCS accreditation and the correct institution name is correctly listed above. Conflicts of interest: The authors have nothing to disclose.",

author = "Zhenjie Wu and Qi Chen and Hooman Djaladat and Andrea Minervini and Uzzo, {Robert G.} and Chandru Sundaram and Rha, {Koon H.} and Gonzalgo, {Mark L.} and Reza Mehrazin and Elio Mazzone and Jamil Marcus and Alyssa Danno and James Porter and Aeen Asghar and Fady Ghali and Georgi Guruli and Antoin Douglawi and Giovanni Cacciamani and Alireza Ghoreifi and Giuseppe Simone and Vitaly Margulis and Matteo Ferro and Riccardo Tellini and Andrea Mari and Abhishek Srivastava and James Steward and Ali Al-Qathani and Ahmad Al-Mujalhem and {Satish Bhattu}, Amit and Alexander Mottrie and Firas Abdollah and Eun, {Daniel D.} and Ithaar Derweesh and Alessandro Veccia and Riccardo Autorino and Linhui Wang",

note = "Publisher Copyright: {\textcopyright} 2021 European Association of Urology",

year = "2024",

month = may,

doi = "10.1016/j.euf.2022.12.010",

language = "English (US)",

volume = "10",

pages = "502",

journal = "European Urology Focus",

issn = "2405-4569",

publisher = "Elsevier BV",

number = "3",

}

TY - JOUR

T1 - Corrigendum re “A Preoperative Nomogram to Predict Renal Function Insufficiency for Cisplatin-based Adjuvant Chemotherapy Following Minimally Invasive Radical Nephroureterectomy (ROBUUST Collaborative Group)” [Eur Urol Focus 2022;8:173–81] (European Urology Focus (2022) 8(1) (173–181), (S2405456921000158), (10.1016/j.euf.2021.01.014))

AU - Wu, Zhenjie

AU - Chen, Qi

AU - Djaladat, Hooman

AU - Minervini, Andrea

AU - Uzzo, Robert G.

AU - Sundaram, Chandru

AU - Rha, Koon H.

AU - Gonzalgo, Mark L.

AU - Mehrazin, Reza

AU - Mazzone, Elio

AU - Marcus, Jamil

AU - Danno, Alyssa

AU - Porter, James

AU - Asghar, Aeen

AU - Ghali, Fady

AU - Guruli, Georgi

AU - Douglawi, Antoin

AU - Cacciamani, Giovanni

AU - Ghoreifi, Alireza

AU - Simone, Giuseppe

AU - Margulis, Vitaly

AU - Ferro, Matteo

AU - Tellini, Riccardo

AU - Mari, Andrea

AU - Srivastava, Abhishek

AU - Steward, James

AU - Al-Qathani, Ali

AU - Al-Mujalhem, Ahmad

AU - Satish Bhattu, Amit

AU - Mottrie, Alexander

AU - Abdollah, Firas

AU - Eun, Daniel D.

AU - Derweesh, Ithaar

AU - Veccia, Alessandro

AU - Autorino, Riccardo

AU - Wang, Linhui

PY - 2024/5

Y1 - 2024/5

N2 - In the original publication, affiliation p was listed as Department of Urology, Regina Elena National Cancer Institute, Rome, Italy. The authors would like it to be noted that the institution for this affiliation has IRCCS accreditation and the correct institution name is correctly listed above. Conflicts of interest: The authors have nothing to disclose.

AB - In the original publication, affiliation p was listed as Department of Urology, Regina Elena National Cancer Institute, Rome, Italy. The authors would like it to be noted that the institution for this affiliation has IRCCS accreditation and the correct institution name is correctly listed above. Conflicts of interest: The authors have nothing to disclose.

UR - http://www.scopus.com/inward/record.url?scp=85146020599&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85146020599&partnerID=8YFLogxK

U2 - 10.1016/j.euf.2022.12.010

DO - 10.1016/j.euf.2022.12.010

M3 - Comment/debate

C2 - 36588010

AN - SCOPUS:85146020599

SN - 2405-4569

VL - 10

SP - 502

JO - European Urology Focus

JF - European Urology Focus

IS - 3

ER -

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this